A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

Döhner, Hartmut, Müller-Tidow, Carsten, Lübbert, Michael, Fiedler, Walter, Krämer, Alwin, Westermann, Jörg, Bug, Gesine, Schlenk, Richard F., Krug, Utz, Goeldner, Rainer-Georg, Hilbert, James, Taube, Tillmann and Ottmann, Oliver G. ORCID: https://orcid.org/0000-0001-9559-1330 2019. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. British Journal of Haematology 185 (3) , pp. 583-587. 10.1111/bjh.15563

Preview

PDF - Accepted Post-Print Version Download (428kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Publisher:	Wiley
ISSN:	0007-1048
Date of First Compliant Deposit:	7 January 2019
Date of Acceptance:	7 January 2019
Last Modified:	29 Nov 2024 02:45
URI:	https://orca.cardiff.ac.uk/id/eprint/118155

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item